13F-HR filed by Vestal Point Capital, LP
Vestal Point Capital, LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 60 holding rows worth $1,341,135,648.
- Accession
- 0001974915-24-000006
- Filer
- CIK 1974915
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 60 entries on the cover page, a total value of $1,341,135,648 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,341,135,648 with VALUE read as dollars as filed, 13F file number 028-23784. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,500,000 | $160,095,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,075,000 | $112,423,500 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 750,000 | $102,285,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 1,800,000 | $73,980,000 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 900,000 | $61,641,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 750,000 | $50,250,000 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 350,000 | $49,934,500 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,200,000 | $48,960,000 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 925,000 | $39,081,250 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 675,000 | $37,253,250 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 2,750,000 | $31,955,000 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 725,000 | $30,370,250 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 3,250,000 | $29,575,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 2,300,000 | $27,094,000 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 6,490,000 | $26,154,700 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,750,000 | $25,970,000 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 5,430,000 | $25,358,100 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 300,000 | $24,150,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 560,000 | $21,991,200 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,830,000 | $21,960,000 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 3,600,000 | $21,708,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 4,750,000 | $21,280,000 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 500,000 | $20,765,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 525,000 | $20,469,750 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 440,000 | $18,198,400 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,250,000 | $17,225,000 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 350,000 | $16,852,500 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 600,000 | $15,528,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 2,665,000 | $15,110,550 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 840,000 | $13,473,600 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 335,000 | $12,850,600 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 1,000,000 | $12,100,000 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 500,000 | $11,610,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 500,000 | $10,435,000 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,100,000 | $9,786,000 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 100,000 | $8,036,000 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 60,000 | $8,029,800 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 280,000 | $8,010,800 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 225,000 | $7,940,250 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,160,000 | $7,192,000 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 620,000 | $6,627,800 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,000,000 | $6,560,000 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 2,200,000 | $5,126,000 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 6,052,000 | $4,806,498 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 600,000 | $4,746,000 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 180,000 | $4,460,400 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 440,000 | $3,744,400 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,200,000 | $3,600,000 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 800,000 | $3,400,000 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 890,000 | $3,328,600 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,315,000 | $3,037,650 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 90,000 | $2,752,200 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 500,000 | $2,440,000 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 300,000 | $2,406,000 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 450,000 | $2,313,000 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,400,000 | $1,226,400 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,500,000 | $1,222,500 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC | 046513206 | COM NEW | 112,000 | $952,000 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 545,000 | $822,950 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 25,000 | $480,250 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001974915-24-000006 | this filing | 2024-08-14 | acceptance time not in the bulk data set |